A Therapeutic Double Whammy: Transcriptional or Post-transcriptional Suppression of Microsatellite Repeat Toxicity by

Ashish N Rao1, Thomas A Cooper2

  • 1Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA; Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX 77030, USA.

Molecular Cell
|November 4, 2017
PubMed

Insights

Microsatellite expansion diseases stem from unstable DNA repeats. Researchers are exploring CRISPR-based strategies, targeting either DNA or RNA, to reduce pathogenic repeat numbers and treat these conditions.

Area of Science:

  • Genetics
  • Molecular Biology
  • Biotechnology

Background:

  • Microsatellite expansion diseases arise from unstable tandem DNA repeats exceeding a pathogenic threshold.
  • These repeat expansions are implicated in various genetic disorders.

Purpose of the Study:

  • To explore novel therapeutic strategies for microsatellite expansion diseases.
  • To evaluate the potential of targeting repeat expansions using deactivated Cas9 (dCas9) systems.

Main Methods:

  • Two distinct approaches utilizing dCas9 were investigated.
  • One strategy targeted the DNA repeats directly.
  • The other strategy targeted the RNA transcripts of the repeats.

Main Results:

  • Both DNA-targeting and RNA-targeting dCas9 strategies demonstrated potential in reducing pathogenic repeat numbers.
  • These findings suggest distinct therapeutic avenues for microsatellite expansion disorders.

Conclusions:

  • Targeting either DNA or RNA repeats with dCas9 offers a promising therapeutic avenue for microsatellite expansion diseases.
  • Further research into these CRISPR-based interventions could lead to effective treatments.

Related Concept Videos

CRISPR01:59

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
58.1K
CRISPR/Cas9 Genome Editing01:28

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
2.1K
Homologous Recombination02:31

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
64.1K
Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
6.9K